Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: V04CD06

Ghryvelin (previously Macimorelin Aeterna Zentaris)(macimorelin acetate)

Diagnostic Techniques, Endocrine

Marketing Authorisation Holder: Atnahs Pharma Netherlands B.V.

EMA Authorisation: 11/01/2019

INN: macimorelin

Indication

This medicinal product is for diagnostic use only. GHRYVELIN is indicated for the diagnosis of growth hormone deficiency (GHD) in adults.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Ghryvelin (previously Macimorelin Aeterna Zentaris) — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.